Rufei Liu
Overview
Explore the profile of Rufei Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng K, Yan Y, Ma L, Liu R, Zhao T, Wei Y, et al.
BMC Endocr Disord
. 2025 Feb;
25(1):44.
PMID: 39966782
Background: Abnormal lipid profiles are a major risk factor for cardiovascular diseases, and childhood obesity has been linked to changes in lipid metabolism in adults. However, the relationship between childhood...
2.
Li X, Wu M, Chen M, Liu R, Tao Q, Hu Y, et al.
Cancer Med
. 2025 Jan;
14(2):e70527.
PMID: 39831739
Background: Neutrophils interact with tumor cells, potentially exacerbating cancer progression. Additionally, decreased albumin levels are a marker of poor cancer prognosis. The neutrophil-percentage-to-albumin ratio (NPAR) has been used for prognostic...
3.
Liu R, Cheng W
Curr Hypertens Rev
. 2024 Dec;
PMID: 39686636
Hypertension remains the primary driver of Cardiovascular Diseases (CVDs) and mortality. Dyslipidaemia is a common risk factor for CVDs in hypertensive patients, and their coexistence significantly increases the risk of...
4.
Huang X, Tian B, Ren Z, Zhang J, Yan W, Mo Y, et al.
Ther Adv Med Oncol
. 2024 Oct;
16:17588359241289671.
PMID: 39429466
Background: Given that only a small subset of patients with advanced non-small-cell lung cancer (aNSCLC) benefit from immune checkpoint inhibitors (ICIs), the effectiveness of ICIs is often compromised by the...
5.
Ma L, Li Y, Pei J, Wang X, Zheng K, Zhao Z, et al.
Rev Cardiovasc Med
. 2024 Jul;
25(2):46.
PMID: 39077362
Background: The purpose of this study was to evaluate the impact of glucose levels on admission, on the risk of 30-day major adverse cardiovascular events (MACEs) in patients with acute...
6.
Yu T, Liu Z, Tao Q, Xu X, Li X, Li Y, et al.
Cancer Lett
. 2024 Mar;
589:216824.
PMID: 38522774
Immunotherapy, especially immune checkpoint inhibitors, has revolutionized clinical practice within the last decade. However, primary and secondary resistance to immunotherapy is common in patients with diverse types of cancer. It...
7.
Zheng K, Yin Y, Guo H, Ma L, Liu R, Zhao T, et al.
Front Endocrinol (Lausanne)
. 2024 Feb;
15:1340644.
PMID: 38405152
Background: Non-alcoholic fatty liver disease (NAFLD) is increasingly observed in non-obese individuals. The ZJU (Zhejiang University) index has been established as a new and efficient tool for detecting NAFLD, but...
8.
Liu R, Cheng W
J Clin Hypertens (Greenwich)
. 2024 Feb;
26(3):225-234.
PMID: 38318688
Previous studies in patients with hypertension have demonstrated that there is a U-shaped association between HDL-C (high-density lipoprotein cholesterol) and the risk of cardiovascular events in male patients with hypertension....
9.
Meng X, Wang Q, Zhao X, Cai Y, Fu J, Zhu M, et al.
Waste Manag
. 2023 Jun;
168:246-255.
PMID: 37327518
With the accelerated construction of biogas plants, the amount of biogas residues are expanding. Composting has been widely implemented to deal with biogas residues. Aeration regulation is the main factor...
10.
Liu J, Zuo X, Peng K, He R, Yang L, Liu R
Appl Biochem Biotechnol
. 2021 Sep;
194(2):762-782.
PMID: 34524637
The anaerobic digestion efficiency and methane production of straw was limited by its complex composition and structure. In this study, rice straw (RS), cellulose, and hemicellulose were used as raw...